Thu, Apr 24, 2014, 12:15 PM EDT - U.S. Markets close in 3 hrs 45 mins

Recent

% | $
Quotes you view appear here for quick access.

Protalix BioTherapeutics, Inc. (PLX) Message Board

  • plxbrazilplx plxbrazilplx Nov 13, 2012 11:04 AM Flag

    article

    translate to english

    Protalix Closer agreement for the sale of its drug for Gaucher disease Brazilian government, hundreds of millions of dollars. Sources close to the deal told Globes "that the agreement could be signed within a few days.
    Negotiations with the government of Brazil manages Protalix with pharmaceutical giant Pfizer, which markets the drug exclusively Protalix world (except Israel, which markets the drug alone Protalix). Pfizer and Protalix share the revenue from the drug - 60% and 40% Pfizer Protalix. Pfizer is responsible for marketing and marketing expenses, and Protalix is ​​responsible for the production and expenses related to it. Protalix declined to comment.
    More Globes "that the agreement would be worth 300-400 million, and will also include elements beyond the sale of the drug doses Brazilian government. Will probably grant or benefit agreement for the sale of knowledge or establishing a manufacturing plant in Brazil Protalix drug

 
PLX
4.18+0.01(+0.36%)12:01 PMEDT

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.